G20 Global Pharma Summit Series-Indonesia

Advances in RNA production, purification, and cellular transport have facilitated the creation of mRNA vaccines for a wide range of applications, including cancer and Zika virus infection. The technique is inexpensive, easy to build, and induces immunity in an unusual way. An successful COVID-19 vaccine was created, manufactured, licenced, and deployed in less than a year, thanks to previous research that lay the framework for this technology. This game-changing technology has the potential to be utilised to rapidly and efficiently manage some of healthcare's most difficult ailments.